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1.1. X-ray crystallographic detection of ligands
Dynamic combinatorial chemistry (DCC) is an approach
to molecular recognition where speciﬁc members of a
combinatorial library are selected and ampliﬁed with the
use of a template. The principle diﬀerence between
DCC and traditional combinatorial chemistry is that the
reaction linking the building blocks together in DCC is
reversible and there is an ongoing interchange between
diﬀerent members of the dynamic combinatorial library
(DCL) under thermodynamic control.ADCL is thus able
to respond to molecular recognition events with a tem-
plate, such as a protein, which can stabilise a particular
member of the library and induce a shift in the equilib-
rium, favouring the formation of the selected species.
A complementary approach has now been reported in
which ligands are observed directly by X-ray crystal-
lography of a protein exposed to a dynamic combina-
torial library mixture.1 The approach outlined by the
authors was used to detect potent inhibitors of the cy-
clin-dependent kinase 2 protein (CDK2). A feature of
this technique is that the direct identiﬁcation of ligands
from the mixture of components in the DCL, and a
detailed binding mode can be deﬁned from the electron-
density maps. It has been established with both X-ray
crystallography and NMR spectroscopic techniques that
very small molecules (‘fragments’) with molecular
weights of between 100–200 are capable of binding to
proteins in a reproducible manner, even though their
intrinsic potency, as determined by in vitro biological
assay, is very weak (IC50 in the lm – mM range).
It has been postulated that fragments bound to adjacent
pockets within the active site of a protein could, in
principle, self-assemble to generate larger, more potentE-mail: nick_terrett@cambridge.pﬁzer.com
doi:10.1016/j.comche.2004.04.002ligands if they had appropriate chemical reactivities. To
explore this the possibility, CDK2 was used for a proof-
of-concept study. The ﬁrst studies were performed with
individual crystals of CDK2 soaked in reaction solutions
containing monomers (i) and the isatin (ii) which, under
equilibrium conditions, went on to form compounds of
general structure (iii). Compounds (iii) that were shown
to bind to CDK2 by X-ray crystallography, were then
resynthesised in solution and puriﬁed. The activity was
then determined in a CDK2 assay. One of the most po-
tent discovered was (iv) which possessed a IC50 of 30 nM.
This work has shown that it is possible to use X-ray
crystallography to detect potent small-molecule ligands
generated by DCL in situ and bound to a target protein.
This technology may be applicable to the discovery of
inhibitors of other therapeutically useful proteins within
drug discovery programs.
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The formation of new blood vessels (angiogenesis) is an
essential prerequisite for the growth of aggressive solid
tumours but a rare event in adult physiology. Overexu-
berant angiogenesis is a characteristic feature of blinding
ocular disorders (e.g. diabetic retinopathy and age-
related macular degeneration) and rheumatoid arthritis.
Markers of angiogenesis therefore represent an ideal
target for molecular intervention.
Fibronectin is a multidomain adhesive glycoprotein,
present in diﬀerent isoforms, that is abundant in plasma
and tissues. One of the extra domains, the ED-B do-
main, has a 91 amino acid sequence that is identical in
mouse, rat and human. ED-B-containing ﬁbronectin (B-
FN) has a restricted pattern of expression, being unde-
tectable in normal adult tissues and in mature blood
vessels, but accumulates in regenerating tissue around
new blood vessels. A recent study has identiﬁed lead
compounds speciﬁc to the ED-B domain of ﬁbronectin
using NMR screening of a small rationally designed
library of low molecular-weight compounds.2
A library of 113 compounds was synthesised in solution
and tested for binding, in mixtures of ﬁve compounds,
to 15N-labelled ED-B. The spectrum of each mixture was
recorded and compared with a reference spectrum of
15N-labeled ED-B. From this comparison, one mixture
was seen to produce a large resonance shift of the signal
from a single backbone amide group. Deconvolution of
this mixture and re-screening individually each of these
ﬁve compounds led to the identiﬁcation of the small
molecule (v) as the most potent binder to ED-B, binding
with a dissociation constant Kd in excess of 5 mM. This
work has provided a small molecule starting point for
the design of multidentate ED-B binders with improved
aﬃnity.
NH3+
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2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
A combinatorial library of isoxazoles has been prepared
by 1,3-dipolar cycloaddition on solid support.32.2. Solution-phase synthesis
The discovery of oxazolo-pyrimidines as structurally
novel adenosine kinase inhibitors has been reported.
High throughput derivatisation of the oxazolo-pyrim-
idine scaﬀold was performed using liquid phase parallel
synthesis techniques.42.3. Scaﬀolds for combinatorial libraries
The solid-phase synthesis of 3-alkyl-2-arylamino-3,4-
dihydroquinazolines using an N-Fmoc-b-amino-2-ni-
trobenzenepropanoic acid scaﬀold has been described.5
After Fmoc deprotection, the resin-bound scaﬀold was
reductively alkylated with aldehydes or ketones, fol-
lowed by reduction of the nitro group with tin(II)
chloride and subsequent cyclisation of the 1,3-diamine
intermediates with aryl isothiocyanates in the presence
of 1,3-diisopropylcarbodiimide (DIC).
Treatment of [1,3,5]triazine-2,4,6-tricarboxylic acid tri-
ethyl ester with arylhydrazines provided 5-amino-6-oxo-
1,6-dihydro[1,2,4]triazine-3-carboxylic acid ethyl esters.6
These building blocks served as starting points for the
syntheses of two discrete exocyclic 5-amido and 3-amido
compound libraries.
Tris-1,1,1-(hydroxymethyl)ethane was converted to a
series of mono- and disubstituted derivatives and the use
of this precursor as a scaﬀold for combinatorial chem-
istry has been demonstrated.7
Synthesis and characterization of several new anomeri-
cally pure galactose derivatives has been described.8 The
monosaccharides described contain selectively pro-
tected/deprotected hydroxyl functionalities at their
1,2,3,4- and 6-positions rendering them useful as build-
ing blocks for construction of branched oligosaccharides
libraries.2.4. Solid-phase supported reagents
Addition of an inexpensive polymer-bound chelate
phosphine to ring-closing metathesis reaction mixtures
eﬀectively removes coloured impurities and delivers
ruthenium-free reaction products.9
Commercially-available polymer-supported reagents
have been used to facilitate both cyclisation and puriﬁ-
cation in a robust one-pot solution-phase synthesis of 2-
amino-1,3,4-oxadiazoles directly from acylhydrazines
and isothiocyanates.10
Novel solid-supported phosphonate reagents have been
prepared and evaluated for the synthesis of, a, b-
unsaturated esters with a preference for the Z-alkene.112.5. Novel resins, linkers and techniques
An alkoxyacetyl group (AAc) group has been reported
to be an eﬃcient linker for high-throughput synthesis of
small molecules on a soluble polymer support.12 The
linker allows high-yield loading of alcohols and phenols
either by conventional carbodiimide-mediated esteriﬁ-
cation or transesteriﬁcation using Yb(OTf)3.
A novel linker for solid phase synthesis, incorporating a
pyridyl propionate system with a pendant b-silyl group,
has been described, which exhibits rapid cleavage under
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der acidic conditions.13
An extension of the T2 linker methodology by showing
its applicability as a photocleavable linker has been re-
ported.14 This linker, stable under a wide range of
conditions, is suitable for protected amino acid deriva-
tives, as well as simple small organic molecules including
resin-bound biotin.2.6. Library applications
A facile solid-phase methodology for the production of
cholesterol-based polyamines useful in mediating nucleic
acid delivery for gene therapy has been described.15 The
methodology is compatible with a range of polyamines
producing a library of lipids in excellent yields and purity.
In order to develop new tools for studying mucin-type
O-linked glycosylation, a 1338 member uridine-based
library has been prepared to identify small molecule
inhibitors of polypeptide N-acetyl-a-galactosaminyl-
transferases (ppGalNAcTs).16 Using a high-throughput
enzyme-linked lectin assay, two inhibitors of murine
ppGalNAcT-1 were identiﬁed that also inhibit several
other members of the family.
A library of constrained 9-mer and 13-mer peptides that
form stable folded structures has been screened for ap-
tamers that bind with high aﬃnity to the ﬂuorescent dye
Texas red.17 The peptides interact with distinct but
overlapping regions of Texas red.
New arylpiperazines related to buspirone, gepirone and
NAN-190 were designed and screened in silico for their
5-HT1A aﬃnity and potential sites of metabolism by
human cytochrome P450 (CYP3A4).18 Selected new
molecules were synthesized and puriﬁed in a parallel
chemistry approach to determine structure activity
relationships.
High-throughput screening of two million compounds
in 37 distinct encoded combinatorial libraries using FSH
receptor transfected cells provided small molecule ag-
onists.19 A focused combinatorial library with a total of
31,372 compounds was designed, synthesized, and
screened to reveal 72 novel biaryl FSH receptor agonists
as well as a unique combinatorial SAR.
Potent small molecule biaryl diketopiperazine FSH
receptor agonists have been discovered through the de-
sign, synthesis and evaluation of three biaryl diketo-
piperazine optimization libraries with over 300
compounds.20 These libraries were prepared via solid-
phase parallel synthesis using a cyclization-release
method.
Highly active ﬂuorescent compounds having kappa
opioid activity have been identiﬁed following the
screening in a kappa-speciﬁc radioligand binding assay of
a positional scanning tetrapeptide combinatorial library
in which every tetrapeptide was ﬂuorescently labelled.21Parallel synthesis of C-terminal-modiﬁed DAPT deriv-
atives was accomplished by condensation of a polymer
bound N-acylamino acid with several amines.22 Among
the analogues synthesised, a benzophenonemethyl
amide derivative showed 30 times more potent activity
than the original DAPT.
A combinatorial hexapeptide library was synthesized on
a TentaGel NH2 resin using the one-bead one-sequence
protocol and a unique peptide sequence of HGGHHG
discovered from screening this library showed an ability
to chelate a transition metal on a chip better than hexa-
His peptide.23
A recent paper describes glycorandomisation, a
chemoenzymatic strategy that overcomes the limitations
in natural product derivatisation associated with both
solely chemistry-based approaches.24 This has led to the
synthesis of glycorandomised libraries with possibilities
for subsequent chemistry derivatisation.
A recent review has described how modifying enzymes
for use in organic solvents has opened up the use of
enzymes for the synthesis of new innovative medicines
such as carbohydrates and their incorporation in mod-
ern methods for drug development, such as combina-
torial chemistry.25References
1. Congreve, M. S.; et al. Angew. Chem., Int. Ed. 2003, 42
(37), 4479–4482.
2. Scheuermann, J.; et al. Drug Dev. Res. 2003, 58 (3), 268–
282.
3. Haino, T.; et al. Tetrahedron Lett. 2004, 45 (11), 2277–
2279.
4. Bauser, M.; et al. Bioorg. Med. Chem. Lett. 2004, 14 (8),
1997–2000.
5. Song, A.; et al. Tetrahedron Lett. 2004, 45 (13), 2727–
2730.
6. Gambert, R.; et al. Tetrahedron Lett. 2004, 45 (13), 2791–
2795.
7. Clarke, P.; et al. Tetrahedron 2004, 60 (16), 3625–3636.
8. Lehtil€a, R. L.; et al. Tetrahedron 2004, 60 (16), 3653–3661.
9. Westhus, M.; et al. Tetrahedron Lett. 2004, 45 (15), 3141–
3142.
10. Coppo, F. T.; et al. Tetrahedron Lett. 2004, 45 (16), 3257–
3260.
11. Martina, S. L. X.; Taylor, R. J. K. Tetrahedron Lett. 2004,
45 (16), 3279–3282.
12. Oikawa, M.; et al. Tetrahedron Lett. 2004, 45 (11), 2371–
2375.
13. Ramage, R.; et al. Tetrahedron Lett. 2004, 45 (11), 2403–
2404.
14. Enders, D.; et al. Tetrahedron Lett. 2004, 45 (13), 2839–
2841.
15. Oliver, M.; et al. Tetrahedron Lett. 2004, 45 (15), 3105–
3107.
16. Hang, H. C.; et al. Chem. Biol. 2004, 11 (3), 337–345.
17. Marks, K. M.; et al. Chem. Biol. 2004, 11 (3), 347–356.
18. Tandon, M.; et al. Bioorg. Med. Chem. Lett. 2004, 14 (7),
1709–1712.
19. Guo, T.; et al. Bioorg. Med. Chem. Lett. 2004, 14 (7),
1713–1716.
20 N. K. Terrett / Combinatorial Chemistry - An Online Journal 6 (2004) 17–2020. Guo, T.; et al. Bioorg. Med. Chem. Lett. 2004, 14 (7),
1717–1720.
21. Houghten, R. A.; et al. Bioorg. Med. Chem. Lett. 2004, 14
(8), 1947–1951.
22. Kan, T.; et al. Bioorg. Med. Chem. Lett. 2004, 14 (8),
1983–1985.
23. Cheng, C.-W.; et al. Bioorg. Med. Chem. Lett. 2004, 14
(8), 1987–1990.
24. Yang, J.; et al. Bioorg. Med. Chem. 2004, 12 (7), 1577–
1584.
25. Garcıa-Junceda, E.; et al. Bioorg. Med. Chem. 2004, 12
(8), 1817–1834.Further Reading
Papers on combinatorial chemistry or solid-phase synthesis from
other journals
Harper, G.; Pickett, S. D.; Green, D. V. S. Design of a
compound screening collection for use in high throughput
screening. Combinatorial Chemistry and High Throughput
Screening 2004, 7 (1), 63–71.
Lin, M.-J.; Sun, C.-M. Focused microwave-assisted parallel
synthesis of bis-benzimidazoles. Synlett 2004; (4), 663–666.
Huenger, U.; Ohnsmann, J.; Kunz, H. Carbohydrate scaﬀolds
for combinatorial syntheses that allow selective deprotec-
tion of all four positions independent of the sequence.
Angewandte Chemie, International Edition 2004, 43 (9),
1104–1107.
Whitney, A. M.; Ladame, S.; Balasubramanian, S. Templated
ligand assembly by using G-quadruplex DNA and dynamic
covalent chemistry. Angewandte Chemie, International Edi-
tion 2004, 43 (9), 1143–1146.
Smietana, M.; Johnson, R. B.; Wang, Q. M.; Kool, E. T.
Solid-phase synthesis and combinatorial library screening
of macrocyclic nucleotide-hybrid compounds targeted to
hepatitis C NS5B. Chemistry––A European Journal 2004, 10
(1), 173–181.
De Leon-Rodriguez, L. M.; Kovacs, Z.; Dieckmann, G. R.;
Sherry, A. D. Solid-phase synthesis of DOTA-peptides.
Chemistry––A European Journal 2004, 10 (5), 1149–
1155.
Lagnoux, D.; Delort, E.; Douat-Casassus, C.; Esposito, A.;
Reymond, J.-L. Synthesis and esterolytic activity of cata-
lytic peptide dendrimers. Chemistry––A European Journal
2004, 10 (5), 1215–1226.
Gonzalez-Alvarez, A.; Alfonso, I.; Lopez-Ortiz, F.; Aguirre,
A.; Garcia-Granda, S.; Gotor, V. Selective host ampliﬁca-
tion from a dynamic combinatorial library of oligoiminesfor the syntheses of diﬀerent optically active polyazamac-
rocycles. European Journal of Organic Chemistry 2004; (5),
1117–1127.
Yadav, V.; Chu, C. K.; Rais, R. H.; Al Safarjalani, O. N.;
Guarcello, V.; Naguib, F. N. M.; El Kouni, M. H.
Synthesis, biological activity and molecular modeling of
6-benzylthioinosine analogues as subversive substrates of
Toxoplasma gondii adenosine kinase. Journal of Medicinal
Chemistry 2004, 47 (8), 1987–1996.
Sheng, S.-R.; Zhou, W.; Liu, X.-L.; Song, C.-S. A convenient
selenium-linking strategy for traceless solid-phase synthesis
of diethyl 1-alkenephosphonates. Synthetic Communica-
tions 2004, 34 (6), 1011–1016.
Tanaka, H.; Hasegawa, T.; Iwashima, M.; Iguchi, K.; Taka-
hashi, T. Eﬃcient solid-phase synthesis of clavulones via
sequential coupling of a- and x-chains. Organic Letters
2004, 6 (7), 1103–1106.
Hu, Y.; Nawoschik, K. J.; Liao, Y.; Ma, J.; Fathi, R.; Yang, Z.
Synthesis of conformationally restricted 2,3-diaryl-
benzo[b]furan by the Pd-catalyzed annulation of o-alkynyl-
phenols: exploring a combinatorial approach. Journal of
Organic Chemistry 2004, 69 (7), 2235–2239.
Xu, J.; Szakal, C. W.; Martin, S. E.; Peterson, B. R.; Wucher,
A.; Winograd, N. Molecule-speciﬁc imaging with mass
spectrometry and a buckminsterfullerene probe: application
to characterizing solid-phase synthesized combinatorial
libraries. Journal of the American Chemical Society 2004,
126 (12), 3902–3909.
Rosenstroem, U.; Skoeld, C.; Lindeberg, G.; Botros, M.;
Nyberg, F.; Karlen, A.; Hallberg, A. A selective AT2
receptor ligand with a c-turn-like mimetic replacing the
amino acid residues 4–5 of angiotensin II. Journal of
Medicinal Chemistry 2004, 47 (4), 859–870.
Paul, H.; Basu, S.; Bhaduri, S.; Lahiri, G. K. Platinum
carbonyl derived catalysts on inorganic and organic
supports: a comparative study. Journal of Organometallic
Chemistry 2004, 689 (2), 309–316.
Maclean, D.; Holden, F.; Davis, A. M.; Scheuerman, R. A.;
Yanofsky, S.; Holmes, C. P.; Fitch, W. L.; Tsutsui, K.;
Barrett, R. W.; Gallop, M. A. Agonists of the follicle
stimulating hormone receptor from an encoded thiazolid-
inone library. Journal of Combinatorial Chemistry 2004, 6
(2), 196–206.
Im, I.; Webb, T. R.; Gong, Y.-D.; Kim, J.-I.; Kim, Y.-C.
Solid-phase synthesis of tetrahydro-1,4-benzodiazepin-2-
one derivatives as a b-turn peptidomimetic library. Journal
of Combinatorial Chemistry 2004, 6 (2), 207–213.
Georgiadis, T. M.; Baindur, N.; Player, M. R. Solid-phase
synthesis of an oxalic acid amide library. Journal of
Combinatorial Chemistry 2004, 6 (2), 224–229.
